Ventilation during Cardiopulmonary Bypass

Phase 2

• Conditions: Genearl Anesthesia in Coronary Disease.; Atherosclerotic cardiovascular disease, so described

• Registration Number: IRCT138902283954N1
• Lead Sponsor: Research deputy of Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Exclusion criteria were: ASA (American Society of Anesthesia) class> III, age> 70 years, poor left ventricular function (LVEF <40%), valvular heart disease,
re operation, renal impairment and significant pulmonary disease as defined by preoperative FEV1 and FVC values less than 40% of predicted

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PaO2. Timepoint: after induction of anesthesia and endotracheal intubation and before sternotomy, 5 minutes , 2 and 4 hours after completion of CPB and after extubation in ICU. Method of measurement: mm/Hg.;FEV1. Timepoint: Time of extubation, preoperative and in the 5th postoperative day. Method of measurement: Liter.;FVC. Timepoint: Time of extubation, preoperative and in the 5th postoperative day. Method of measurement: Liter.